- Report
- July 2020
- 203 Pages
Global
From €8524EUR$9,500USD£7,337GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
Pranoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat inflammation and pain associated with optical disorders. It is a topical ophthalmic solution that is applied directly to the eye. Pranoprofen is used to treat conditions such as uveitis, iritis, and scleritis. It is also used to treat post-operative inflammation and pain following cataract surgery. Pranoprofen works by inhibiting the production of prostaglandins, which are responsible for inflammation and pain.
Pranoprofen is available in both generic and brand-name formulations. It is typically prescribed as a single-dose application, although multiple doses may be necessary for some conditions. Pranoprofen is generally well-tolerated, with few side effects reported.
The Pranoprofen market is an important part of the Optical Disorders Drugs market. It is used to treat a variety of conditions, and is generally well-tolerated with few side effects.
Some companies in the Pranoprofen market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more